Cargando…
Ulcerative Colitis: Current and Emerging Treatment Strategies
Historically, medical therapy for ulcerative colitis (UC) was limited to corticosteroids. Excitingly, over the past just 1–2 decades, the options for medical therapy have expanded and include biologics and small molecules, with more agents actively being developed. In this article, we review the cur...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019865/ https://www.ncbi.nlm.nih.gov/pubmed/31905945 http://dx.doi.org/10.3390/jcm9010094 |
_version_ | 1783497618715836416 |
---|---|
author | Kayal, Maia Shah, Shailja |
author_facet | Kayal, Maia Shah, Shailja |
author_sort | Kayal, Maia |
collection | PubMed |
description | Historically, medical therapy for ulcerative colitis (UC) was limited to corticosteroids. Excitingly, over the past just 1–2 decades, the options for medical therapy have expanded and include biologics and small molecules, with more agents actively being developed. In this article, we review the current and emerging treatment strategies for UC stratified according to disease severity. |
format | Online Article Text |
id | pubmed-7019865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70198652020-03-09 Ulcerative Colitis: Current and Emerging Treatment Strategies Kayal, Maia Shah, Shailja J Clin Med Review Historically, medical therapy for ulcerative colitis (UC) was limited to corticosteroids. Excitingly, over the past just 1–2 decades, the options for medical therapy have expanded and include biologics and small molecules, with more agents actively being developed. In this article, we review the current and emerging treatment strategies for UC stratified according to disease severity. MDPI 2019-12-30 /pmc/articles/PMC7019865/ /pubmed/31905945 http://dx.doi.org/10.3390/jcm9010094 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kayal, Maia Shah, Shailja Ulcerative Colitis: Current and Emerging Treatment Strategies |
title | Ulcerative Colitis: Current and Emerging Treatment Strategies |
title_full | Ulcerative Colitis: Current and Emerging Treatment Strategies |
title_fullStr | Ulcerative Colitis: Current and Emerging Treatment Strategies |
title_full_unstemmed | Ulcerative Colitis: Current and Emerging Treatment Strategies |
title_short | Ulcerative Colitis: Current and Emerging Treatment Strategies |
title_sort | ulcerative colitis: current and emerging treatment strategies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019865/ https://www.ncbi.nlm.nih.gov/pubmed/31905945 http://dx.doi.org/10.3390/jcm9010094 |
work_keys_str_mv | AT kayalmaia ulcerativecolitiscurrentandemergingtreatmentstrategies AT shahshailja ulcerativecolitiscurrentandemergingtreatmentstrategies |